Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Bisphosphonates for Osteoporosis Reduce Risk for Breast Cancer
Link ID 27103
Title Bisphosphonates for Osteoporosis Reduce Risk for Breast Cancer
Url http://www.medscape.com/viewarticle/725429?src=rss
Description Two retrospective studies suggesting that postmenopausal women who take oral bisphosphonates for osteoporosis have a reduced risk for breast cancer have now been published. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Jul 21, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. FDA Warns of Increased Cancer Risk With TNF Blockers in Children
  The FDA is requiring Boxed Warnings on the labeling of TNF blockers to include information about increased risk for lymphoma and other cancers in children and adolescents taking these drugs. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Dr. David C. Hohn Receives Courage Award
  David C. Hohn, MD, has received the Gilda Radner Courage Award for his achievements in cancer research, administrative leadership, and advocacy for other cancer patients. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Needle Core Biopsy Characteristics Identify Patients At Risk of Compromised Margins in Breast Conser
  This study investigates the value of needle core biopsy findings, in particular, the relative quantity of ductal carcinoma in situ, in improving patient selection for breast conservation.
Modern Pathology
Category:   Articles > Hematology-Oncology


4. Ask the Experts About Breast Cancer: Trastuzumab Dose and Schedule in the Metastatic Setting
  The long serum half-life of trastuzumab permits a variety of doses and schedules, in conjunction with chemotherapy or not, for patients with metastatic breast cancer.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. New Advances in the Treatment of Chronic Myelogenous Leukemia
  Review the development of imatinib resistance and management strategies for CML patients who develop resistance.
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS